Compare $CLPT vs $OBIO | Chartloom

Compare

$CLPT vs $OBIO

Clearpoint Neuro Inc · Orchestra Biomed Holdings Inc

CLPT

Clearpoint Neuro Inc

OBIO

Orchestra Biomed Holdings Inc

Compare $CLPT vs $OBIO

Comparing Clearpoint Neuro Inc and Orchestra Biomed Holdings Inc

CLPTClearpoint Neuro Inc

OBIOOrchestra Biomed Holdings Inc

CLPTClearpoint Neuro Inc

Market cap

$314M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.82x

Rev growth (TTM)

25.9%

YTD performance

-25.3%

52W performance

-64.6%

FCF yield

-10.0%

OBIOOrchestra Biomed Holdings Inc

Market cap

$356M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

789.20x

Rev growth (TTM)

986.1%

YTD performance

38.1%

52W performance

105.2%

FCF yield

-16.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLPT

OBIO

Detailed metrics comparison

CLPT

Clearpoint Neuro Inc

OBIO

Orchestra Biomed Holdings Inc

Market Cap

CLPT$314M

OBIO$356M

Enterprise Value

CLPT$335M

OBIO$371M

Price

CLPT$10.48

OBIO$5.95

P/E Ratio

CLPTN/A

OBION/A

P/S Ratio

CLPT7.43x

OBIO11.14x

EV/Sales

CLPT7.93x

OBIO11.59x

EV/EBITDA

CLPT0.00x

OBIO0.00x

P/B Ratio

CLPT30.84x

OBIO12.16x

P/FCF Ratio

CLPTN/A

OBION/A

EV/FCF

CLPT-10.71x

OBIO-6.27x

PEG Ratio

CLPTN/A

OBION/A

Forward P/E (NTM)

CLPTN/A

OBION/A

Forward P/S (NTM)

CLPT5.82x

OBIO789.20x

Revenue (TTM)

CLPT$42M

OBIO$32M

Revenue Growth (YoY)

CLPT25.9%

OBIO986.1%

Forward Rev Growth

CLPT15.4%

OBIO51.2%

Gross Margin (TTM)

CLPT62.6%

OBIO99.5%

Operating Margin (TTM)

CLPT0.0%

OBIO0.0%

EBITDA Margin (TTM)

CLPT-69.3%

OBIO-180.3%

Net Margin (TTM)

CLPT-81.8%

OBIO-186.3%

FCF Margin (TTM)

CLPT-74.0%

OBIO-184.8%

Net Income (TTM)

CLPT$-35M

OBIO$-60M

FCF (TTM)

CLPT$-31M

OBIO$-59M

EPS (TTM)

CLPT-$1.15

OBIO-$0.93

ROE (TTM)

CLPT-18809.0%

OBIO-12578.0%

ROA (TTM)

CLPT-4087.0%

OBIO-5409.0%

ROIC (TTM)

CLPT-5494.0%

OBIO-8895.0%

Cash

CLPT$29M

OBIO$20M

Debt

CLPT$50M

OBIO$35M

Net Cash/Debt

CLPT$-21M

OBIO$-14M

Current Ratio (TTM)

CLPT4.74x

OBIO8.26x

Quick Ratio (TTM)

CLPT3.75x

OBIO8.17x

Debt/Equity (TTM)

CLPT4.66x

OBIO1.18x

Debt/Assets (TTM)

CLPT0.0%

OBIO0.0%

Interest Coverage (TTM)

CLPTN/A

OBION/A

Net Debt/EBITDA (TTM)

CLPT0.00x

OBIO0.00x

Beta

CLPT1.31

OBIO0.55

52W Performance

CLPT-64.6%

OBIO105.2%

YTD Performance

CLPT-25.3%

OBIO38.1%

% from 52W High

CLPT-65.2%

OBIO-8.5%

% from 52W Low

CLPT26.7%

OBIO114.1%

Asset Turnover (TTM)

CLPT0.50x

OBIO0.29x

FCF Yield (TTM)

CLPT-10.0%

OBIO-16.6%

Earnings Yield (TTM)

CLPT-11.0%

OBIO-16.7%

Dividend Yield (TTM)

CLPTN/A

OBION/A

Rule of 40

CLPT-48.2

OBIO801.3

EV/GP/RG

CLPT0.46

OBIO0.17

Ticker research

View CLPT research View OBIO research

Metric	CLPT Clearpoint Neuro Inc	OBIO Orchestra Biomed Holdings Inc
Market & Valuation
Market Cap	$314M	$356M
Enterprise Value	$335M	$371M
Price	$10.48	$5.95
P/E Ratio	N/A	N/A
P/S Ratio	7.43x	11.14x
EV/Sales	7.93x	11.59x
EV/EBITDA	0.00x	0.00x
P/B Ratio	30.84x	12.16x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.71x	-6.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.82x	789.20x
Revenue & Growth
Revenue (TTM)	$42M	$32M
Revenue Growth (YoY)	25.9%	986.1%
Forward Rev Growth	15.4%	51.2%
Profitability
Gross Margin (TTM)	62.6%	99.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-69.3%	-180.3%
Net Margin (TTM)	-81.8%	-186.3%
FCF Margin (TTM)	-74.0%	-184.8%
Net Income (TTM)	$-35M	$-60M
FCF (TTM)	$-31M	$-59M
EPS (TTM)	-$1.15	-$0.93
ROE (TTM)	-18809.0%	-12578.0%
ROA (TTM)	-4087.0%	-5409.0%
ROIC (TTM)	-5494.0%	-8895.0%
Financial Health
Cash	$29M	$20M
Debt	$50M	$35M
Net Cash/Debt	$-21M	$-14M
Current Ratio (TTM)	4.74x	8.26x
Quick Ratio (TTM)	3.75x	8.17x
Debt/Equity (TTM)	4.66x	1.18x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.31	0.55
52W Performance	-64.6%	105.2%
YTD Performance	-25.3%	38.1%
% from 52W High	-65.2%	-8.5%
% from 52W Low	26.7%	114.1%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	0.29x
FCF Yield (TTM)	-10.0%	-16.6%
Earnings Yield (TTM)	-11.0%	-16.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-48.2	801.3
EV/GP/RG	0.46	0.17
Ticker research	View CLPT research	View OBIO research

Valuation

P/S Ratio

CLPT

7.43x

OBIO

11.14x

EV/FCF

CLPT

-10.71x

OBIO

-6.27x

Growth & revenue

Revenue Growth TTM

OBIO

986.1%

CLPT

25.9%

Forward Revenue Growth

OBIO

51.2%

CLPT

15.4%

Profitability & performance

Gross Margin

OBIO

99.5%

CLPT

62.6%

ROE

OBIO

-12578.0%

CLPT

-18809.0%

FCF Yield %

CLPT

-10.0%

OBIO

-16.6%

52-Week Performance

OBIO

105.2%

CLPT

-64.6%

Detailed metrics comparison

CLPT

Clearpoint Neuro Inc

OBIO

Orchestra Biomed Holdings Inc

Market Cap

CLPT$314M

OBIO$356M

Enterprise Value

CLPT$335M

OBIO$371M

Price

CLPT$10.48

OBIO$5.95

P/E Ratio

CLPTN/A

OBION/A

P/S Ratio

CLPT7.43x

OBIO11.14x

EV/Sales

CLPT7.93x

OBIO11.59x

EV/EBITDA

CLPT0.00x

OBIO0.00x

P/B Ratio

CLPT30.84x

OBIO12.16x

P/FCF Ratio

CLPTN/A

OBION/A

EV/FCF

CLPT-10.71x

OBIO-6.27x

PEG Ratio

CLPTN/A

OBION/A

Forward P/E (NTM)

CLPTN/A

OBION/A

Forward P/S (NTM)

CLPT5.82x

OBIO789.20x

Revenue (TTM)

CLPT$42M

OBIO$32M

Revenue Growth (YoY)

CLPT25.9%

OBIO986.1%

Forward Rev Growth

CLPT15.4%

OBIO51.2%

Gross Margin (TTM)

CLPT62.6%

OBIO99.5%

Operating Margin (TTM)

CLPT0.0%

OBIO0.0%

EBITDA Margin (TTM)

CLPT-69.3%

OBIO-180.3%

Net Margin (TTM)

CLPT-81.8%

OBIO-186.3%

FCF Margin (TTM)

CLPT-74.0%

OBIO-184.8%

Net Income (TTM)

CLPT$-35M

OBIO$-60M

FCF (TTM)

CLPT$-31M

OBIO$-59M

EPS (TTM)

CLPT-$1.15

OBIO-$0.93

ROE (TTM)

CLPT-18809.0%

OBIO-12578.0%

ROA (TTM)

CLPT-4087.0%

OBIO-5409.0%

ROIC (TTM)

CLPT-5494.0%

OBIO-8895.0%

Cash

CLPT$29M

OBIO$20M

Debt

CLPT$50M

OBIO$35M

Net Cash/Debt

CLPT$-21M

OBIO$-14M

Current Ratio (TTM)

CLPT4.74x

OBIO8.26x

Quick Ratio (TTM)

CLPT3.75x

OBIO8.17x

Debt/Equity (TTM)

CLPT4.66x

OBIO1.18x

Debt/Assets (TTM)

CLPT0.0%

OBIO0.0%

Interest Coverage (TTM)

CLPTN/A

OBION/A

Net Debt/EBITDA (TTM)

CLPT0.00x

OBIO0.00x

Beta

CLPT1.31

OBIO0.55

52W Performance

CLPT-64.6%

OBIO105.2%

YTD Performance

CLPT-25.3%

OBIO38.1%

% from 52W High

CLPT-65.2%

OBIO-8.5%

% from 52W Low

CLPT26.7%

OBIO114.1%

Asset Turnover (TTM)

CLPT0.50x

OBIO0.29x

FCF Yield (TTM)

CLPT-10.0%

OBIO-16.6%

Earnings Yield (TTM)

CLPT-11.0%

OBIO-16.7%

Dividend Yield (TTM)

CLPTN/A

OBION/A

Rule of 40

CLPT-48.2

OBIO801.3

EV/GP/RG

CLPT0.46

OBIO0.17

Ticker research

View CLPT research View OBIO research

Metric	CLPT Clearpoint Neuro Inc	OBIO Orchestra Biomed Holdings Inc
Market & Valuation
Market Cap	$314M	$356M
Enterprise Value	$335M	$371M
Price	$10.48	$5.95
P/E Ratio	N/A	N/A
P/S Ratio	7.43x	11.14x
EV/Sales	7.93x	11.59x
EV/EBITDA	0.00x	0.00x
P/B Ratio	30.84x	12.16x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.71x	-6.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.82x	789.20x
Revenue & Growth
Revenue (TTM)	$42M	$32M
Revenue Growth (YoY)	25.9%	986.1%
Forward Rev Growth	15.4%	51.2%
Profitability
Gross Margin (TTM)	62.6%	99.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-69.3%	-180.3%
Net Margin (TTM)	-81.8%	-186.3%
FCF Margin (TTM)	-74.0%	-184.8%
Net Income (TTM)	$-35M	$-60M
FCF (TTM)	$-31M	$-59M
EPS (TTM)	-$1.15	-$0.93
ROE (TTM)	-18809.0%	-12578.0%
ROA (TTM)	-4087.0%	-5409.0%
ROIC (TTM)	-5494.0%	-8895.0%
Financial Health
Cash	$29M	$20M
Debt	$50M	$35M
Net Cash/Debt	$-21M	$-14M
Current Ratio (TTM)	4.74x	8.26x
Quick Ratio (TTM)	3.75x	8.17x
Debt/Equity (TTM)	4.66x	1.18x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.31	0.55
52W Performance	-64.6%	105.2%
YTD Performance	-25.3%	38.1%
% from 52W High	-65.2%	-8.5%
% from 52W Low	26.7%	114.1%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	0.29x
FCF Yield (TTM)	-10.0%	-16.6%
Earnings Yield (TTM)	-11.0%	-16.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-48.2	801.3
EV/GP/RG	0.46	0.17
Ticker research	View CLPT research	View OBIO research